In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

University of Melbourne

www.unimelb.edu.au

Latest From University of Melbourne

Start-Up Quarterly Statistics: 2017 Fundraising Ends Better Than It Began

But Q4 was the third sequential quarter with a decrease in financing totals. A review of biopharma start-up dealmaking and financing activity from October through December 2017, based on data from Strategic Transactions.

StartUps and SMEs Financing

Venture Funding Deals, June 2015

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging life science companies that have received venture funding, including companies within the In Vitro Diagnostics, Medical Devices, and Pharmaceuticals sectors. This month’s column covers deals announced April through May 2015.

BioPharmaceutical Medical Device

Optogenetics: Start-Ups Head For The Light

Optogenetics – technology to control neurons with light – has swept through basic neuroscience research. Efforts to commercialize optogenetics are complex, but a spunky group of start-ups plan to develop therapies using the technology.

BioPharmaceutical

Autophagy Mechanism In Schizophrenia Revealed

Most of the current industry interest in autophagy – a mechanism cells use to degrade and remove damaged material – is centered on its role as a cancer drug target, but autophagy is also a neuroprotective mechanism. Now, a research team has shown its involvement in schizophrenia, opening the door for new drug and diagnostic development efforts.

BioPharmaceutical Medical Device
See All
UsernamePublicRestriction

Register